JPET Introducing ALZET?ew Model 2006 Pump

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Journal of Pharmacology And Experimental Therapeutics Fast Forward
First published on January 4, 2007; DOI: 10.1124/jpet.106.114678


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
jpet.106.114678v1
321/1/73    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tanel, A.
Right arrow Articles by Averill-Bates, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tanel, A.
Right arrow Articles by Averill-Bates, D. A.


Received for publication October 24, 2006.
Revised December 30, 2006.
Accepted for publication January 2, 2007.

INHIBITION OF ACROLEIN-INDUCED APOPTOSIS BY THE ANTIOXIDANT N-ACETYLCYSTEINE

Andre Tanel 1 Diana A. Averill-Bates 1*

1 Universite du Quebec a Montreal

* Address correspondence to: E-mail: averill.diana{at}uqam.ca

Abstract

Acrolein is a highly electrophilic {alpha},{beta}-unsaturated aldehyde to which humans are exposed in many situations. It is an environmental pollutant that is responsible for multiple respiratory diseases and has been implicated in neurodegenerative diseases such as Alzheimer's disease. The hypothesis of the study is that the antioxidant N-acetylcysteine (NAC), a precursor of glutathione, could protect cells against acrolein-induced apoptosis. Exposure of CHO cells to a non-cytotoxic dose of acrolein (4 fmol/cell) depleted intracellular glutathione to 45% of initial levels. NAC, which increased intracellular glutathione levels by 30%, afforded protection against acrolein-induced cytotoxicity (loss of cell proliferation) and apoptosis. NAC protected against apoptosis by diminishing acrolein-induced activation of the mitochondrial death pathway. NAC inhibited acrolein-induced Bad translocation from the cytosol to the mitochondria, as well as Bcl-2 translocation from mitochondria to the cytosol, evaluated by Western blotting. However, NAC had no effect on acrolein-induced Bax translocation to mitochondria and cytochrome-c liberation into the cytosol. Meanwhile, NAC inhibited depolarisation of mitochondrial membrane potential, evaluated by rhodamine fluorescence using flow cytometry. NAC also inhibited procaspase-9 processing, activation of enzymatic activity of caspases -9, -7 and -8, as well as PARP cleavage induced by acrolein. Inhibition of acrolein-induced apoptosis using NAC was confirmed morphologically by diminished condensation of nuclear chromatin, evaluated by fluorescence microscopy. These findings suggest that NAC could be potentially useful as a protective agent for people exposed to acrolein.


Key words: N-acetylcysteine, acrolein, apoptosis, caspase, glutathione, mitochondria





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2007 by the American Society for Pharmacology and Experimental Therapeutics.